Literature DB >> 25499757

Clinical and radiological characteristics of 17 Chinese patients with pathology confirmed tumefactive demyelinating diseases: follow-up study.

Jiarui Yao1, Dehui Huang1, Qiuping Gui2, Xiaolei Chen3, Xin Lou4, Lei Wu1, Chen Cheng1, Jie Li1, Weiping Wu5.   

Abstract

Tumefactive demyelinating disease is a rare inflammatory demyelinating disease (IDD) of the central nervous system (CNS). The literature lacks a clear and consistent description of the clinical and radiological spectrum of this disorder, and few Chinese cases have been studied. Here we report 17 Chinese patients, with pathology confirmed CNS IDD, who had distinct clinical and imaging features from those in previous reports. Median age at onset was 47 years, with a female to male ratio of 1.1:1. Multifocal lesions were present in nine cases (53%) on their pre-biopsy magnetic resonance imagings (MRIs), with locations predominantly involving periventricular white matter (41%), subcortical white matter (41%), juxtacortical regions (41%), and cortical gray matter (35%). Moderate to severe perilesional edema and/or mass effect were present in 35% of cases. A variety of enhancement patterns were observed; most were heterogeneous, including ring-like, patchy, venular-like, nodular, punctate, and diffuse in a decreased frequency. Perilesional restriction on diffusion-weighted images (DWI) were evident in 70% cases. Clinical course prior to biopsy was a first neurological event in 82% cases. During a median follow-up of 4.1 years, 76% of cases remained as isolated demyelinating syndrome, and 70% experienced a total or near-total recovery regardless of whether they received immunotherapy. Further studies are needed, especially concerning series with pathological confirmation and long-term follow-up information.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chinese; Clinical; Follow-up; Pathology; Radiology; Tumefactive demyelinating disease

Mesh:

Year:  2014        PMID: 25499757     DOI: 10.1016/j.jns.2014.11.027

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.

Authors:  A Siri; Clarisse Carra-Dalliere; X Ayrignac; J Pelletier; B Audoin; S Pittion-Vouyovitch; M Debouverie; C Lionnet; F Viala; D Sablot; D Brassat; J-C Ouallet; A Ruet; B Brochet; L Taillandier; L Bauchet; N Derache; G Defer; P Cabre; J de Seze; C Lebrun Frenay; M Cohen; P Labauge
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

Review 2.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.